Premium
Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community‐based register study
Author(s) -
Duberg AnnSofi,
Törner Anna,
Daviðsdóttir Lóa,
Aleman Soo,
Blaxhult Anders,
Svensson Åke,
Hultcrantz Rolf,
Bäck Erik,
Ekdahl Karl
Publication year - 2008
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/j.1365-2893.2008.00982.x
Subject(s) - medicine , mortality rate , cause of death , hepatitis b virus , hepatitis b , hepatitis c , standardized mortality ratio , population , liver disease , hepatitis c virus , epidemiology , immunology , virology , disease , virus , environmental health
Summary. Studies on chronic viral hepatitis and mortality have often been made on selected populations or in high‐endemic countries. The aim of this study was to investigate the causes of death and the mortality rates in the nationwide cohorts of people chronically infected with hepatitis B virus (HBV) and/or hepatitis C virus (HCV) in Sweden, a low‐endemic country. All notifications on chronic HBV infection and HCV infection 1990–2003 were linked to the Cause of Death Register. A total of 9517 people with chronic HBV infection, 34 235 people with HCV infection and 1601 with chronic HBV–HCV co‐infection were included, and the mean observation times were 6.4, 6.3 and 7.9 years, respectively. The mortality in the cohorts was compared with age‐ and gender‐specific mortality in the general population and standardized mortality ratios (SMR) were calculated. All‐cause mortality was significantly increased, SMR 2.3 (HBV), 5.8 (HCV) and 8.5 (HBV–HCV), with a great excess liver‐related mortality in all cohorts, SMR 21.7, 35.5 and 46.2, respectively. In HCV and HBV–HCV infected there was an increased mortality due to drug‐related psychiatric diagnoses (SMR: 20.7 and 27.6) and external causes (SMR: 12.4 and 11.4), predominantly at younger age. To conclude, this study demonstrated an increased all‐cause mortality, with a great excess mortality from liver disease, in all cohorts. In people with HCV infection the highest excess mortality in younger ages was from drug‐related and external reasons.